Colgate-Palmolive (CL) Set to Announce Quarterly Earnings on Friday

Posted by Stanley Muller on Oct 28th, 2026

Colgate-Palmolive (NYSE:CL – Get Free Report) will likely be issuing its Q3 2026 results before the market opens on Friday, October 30th. Analysts expect the company to announce earnings of $0.9260 per share and revenue of $5.34 billion for the quarter. Individuals are encouraged to explore the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Friday, October 30, 2026 at 8:30 AM ET.

Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its quarterly earnings results on Friday, July 31st. The company reported $0.99 EPS for the quarter, beating the consensus estimate of $0.95 by $0.04. The business had revenue of $5.36 billion during the quarter, compared to analysts’ expectations of $5.36 billion. The company’s quarterly revenue was up 4.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.92 EPS. On average, analysts expect Colgate-Palmolive to post $3.87 EPS for the current fiscal year and $4.07 EPS for the next fiscal year.

Colgate-Palmolive Stock Down 1.0%

Shares of CL stock opened at $92.19 on Wednesday. Colgate-Palmolive has a fifty-two week low of $74.54 and a fifty-two week high of $99.33. The firm’s 50 day moving average price is $89.38 and its two-hundred day moving average price is $89.47.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be given a $0.53 dividend. The ex-dividend date of this dividend is Tuesday, October 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.3%.

Insider Transactions at Colgate-Palmolive

In related news, Director John Cahill sold 4,170 shares of the business’s stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $93.37, for a total value of $389,352.90. Following the transaction, the director owned 28,373 shares in the company, valued at approximately $2,649,187.01. The trade was a 12.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Noel Wallace sold 161,021 shares of the firm’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the transaction, the chief executive officer directly owned 362,231 shares of the company’s stock, valued at approximately $33,296,273.52. This represents a 30.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 175,191 shares of company stock valued at $16,110,903. Corporate insiders own 0.43% of the company’s stock.

Analyst Ratings Changes

CL has been the topic of a number of research reports. JPMorgan Chase & Co. raised their target price on shares of Colgate-Palmolive from $103.00 to $104.00 and gave the company an “overweight” rating in a research note on Monday, October 19th. Bank of America decreased their price target on shares of Colgate-Palmolive from $102.00 to $100.00 and set a “buy” rating for the company in a research report on Friday, October 9th. Citigroup increased their price target on Colgate-Palmolive from $105.00 to $110.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $104.00 price target on shares of Colgate-Palmolive in a report on Tuesday, September 8th. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $101.00 price objective (up from $99.00) on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Thirteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $98.00.

Get Our Latest Stock Report on CL

Colgate-Palmolive Company Profile

(Get Free Report)

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.